Jean-Briac Lesné

Directeur/Membre du Conseil chez

Igyxos SA

Finance

Consumer Services

Health Technology

Profil

Jean-Briac Lesné is currently a Director at Igyxos SA. Previously, he held Director positions at Hemarina SA and Axilum Robotics SAS. He also worked as a Senior Associate at Sofimac Innovation SAS from 2017 to 2020 and as an Associate at INSERM Transfert SA from 2015 to 2018.
Lesné received his undergraduate degree from the University of Rennes and ESCP Europe Campus London.

Postes actifs de Jean-Briac Lesné

Sociétés	Poste	Début
Igyxos SA Igyxos SA Pharmaceuticals: MajorHealth Technology Develops new pharmaceuticals and medical technologies in the field of human fertility	Directeur/Membre du Conseil	-
BPIFrance Investissement SAS BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.	Private Equity Investor	01/06/2020

Tous les postes actifs de Jean-Briac Lesné

Anciens postes connus de Jean-Briac Lesné

Sociétés	Poste	Fin
Sofimac Innovation SAS Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation is an active manager which prefers to invest equity to create or grow limited liability companies in the ICT sector. The firm invests principally in France and Western European countries because they believe that geographical proximity between investee companies and their team is necessary to provide effective support. Sofimac Innovation typically invests €0.5-€1.5 million in the first round in early-stage companies and €0.5-€3 million with co-investors in subsequent rounds when necessary. The firm works in partnership with their investee companies, providing expertise to support them in assessing and positioning their new technology in their competitive environment, measuring and developing the managing team's potential for success and building the foundations that will allow the company to transform the initial concept into reality. Sofimac Innovation aims to invest in companies which have a technological innovation with growth potential, a quality management team, technological intensity and barriers to entry (including intellectual property rights ownership), a large target market with significant growth potential, a robust marketing strategy and a project in its final stage of development.	Analyste en capital-investissement	30/06/2020
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Analyste en capital-investissement	31/08/2018
Axilum Robotics SAS Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures	Directeur/Membre du Conseil	-
Hemarina SA Hemarina SA BiotechnologyHealth Technology Operates as a biotechnology company which develops oxygen carrier	Directeur/Membre du Conseil	-

Voir l'expérience en détail de Jean-Briac Lesné

Formation de Jean-Briac Lesné

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Jean-Briac Lesné

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	8
Sofimac Innovation SAS Sofimac Innovation SAS Investment ManagersFinance Sofimac Innovation is an active manager which prefers to invest equity to create or grow limited liability companies in the ICT sector. The firm invests principally in France and Western European countries because they believe that geographical proximity between investee companies and their team is necessary to provide effective support. Sofimac Innovation typically invests €0.5-€1.5 million in the first round in early-stage companies and €0.5-€3 million with co-investors in subsequent rounds when necessary. The firm works in partnership with their investee companies, providing expertise to support them in assessing and positioning their new technology in their competitive environment, measuring and developing the managing team's potential for success and building the foundations that will allow the company to transform the initial concept into reality. Sofimac Innovation aims to invest in companies which have a technological innovation with growth potential, a quality management team, technological intensity and barriers to entry (including intellectual property rights ownership), a large target market with significant growth potential, a robust marketing strategy and a project in its final stage of development.	Finance
INSERM Transfert SA INSERM Transfert SA Investment ManagersFinance ITSA is an active private equity investment manager focused exclusively on the French biomedical sector, particularly on areas related to INSERM's medical research effort. They favor projects in fields including therapeutic agents, medical devices, diagnostics, tools and technological platforms. The firm invests between EUR 100 and 300 thousand in pre-seed and seed financing. ITSA's investment criteria include sound science, a driven management team, strong IP, a realistic business model with a clearly defined market, and a competitive milestone-driven schedule. They seek to invest in ambitious projects addressing unmet medical needs and potentially leading to dominant market positions. The firm may act as a co-founder, generally sits on the board of their portfolio companies and actively participates in their strategic decisions.	Finance
University of Rennes University of Rennes Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
BPIFrance Investissement SAS BPIFrance Investissement SAS Investment ManagersFinance BPIfrance Investissement is an active manager focused on small, medium and intermdiate-sized businesses with high-growth potential. They favor sectors related to industry and technology and focus on investments in France. The firm invests either directly through dedicated investment funds or indirectly through private equity funds, partnerships and fund of funds managed by third parties. They invest across development stages, from start-ups to small LBO operations resulting from corporate succession issues. Their deal-sourcing process is both regional and national.	Finance
Hemarina SA Hemarina SA BiotechnologyHealth Technology Operates as a biotechnology company which develops oxygen carrier	Health Technology
Axilum Robotics SAS Axilum Robotics SAS Miscellaneous Commercial ServicesCommercial Services Develops and commercializes robotic solutions designed to assist medical professionals in the implementation of technical gestures	Commercial Services
ESCP Europe Campus London ESCP Europe Campus London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Igyxos SA Igyxos SA Pharmaceuticals: MajorHealth Technology Develops new pharmaceuticals and medical technologies in the field of human fertility	Health Technology